Degradation of CFTR by the ubiquitin-proteasome pathway.

Most cases of cystic fibrosis are caused by mutations that interfere with the biosynthetic folding of the cystic fibrosis transmembrane conductance regulator (CFTR), leading to the rapid degradation of CFTR molecules that have not matured beyond the endoplasmic reticulum (ER). The mechanism by which integral membrane proteins including CFTR are recognized and targeted for ER degradation and the proteolytic machinery involved in this process are not well understood. We show here that the degradation of both wild-type and mutant CFTR is inhibited by two potent proteasome inhibitors that induce the accumulation of polyubiquitinated forms of immature CFTR. CFTR degradation was also inhibited by coexpression of a dominant negative ubiquitin mutant and in cells bearing a temperature-sensitive mutation in the ubiquitin-activating enzyme, confirming that ubiquitination is required for rapid CFTR degradation.

• Publication year

  1995

• Venue

  Cell

• Publication date

  1995-10-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0092-8674(95)90240-6PMID 7553863
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin

  1995cited by this paper
• Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 A resolution.

  1995cited by this paper
• The ubiquitin-proteasome proteolytic pathway.

  1994cited by this paper
• Stoichiometry of recombinant cystic fibrosis transmembrane conductance regulator in epithelial cells and its functional reconstitution into cells in vitro.

  1994cited by this paper
• Conformational maturation of CFTR but not its mutant counterpart (delta F508) occurs in the endoplasmic reticulum and requires ATP.

  1994cited by this paper
• Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules.

  1994cited by this paper
• Participation of the endoplasmic reticulum chaperone calnexin (p88, IP90) in the biogenesis of the cystic fibrosis transmembrane conductance regulator.

  1994cited by this paper
• Inhibition of proteolysis and cell cycle progression in a multiubiquitination-deficient yeast mutant

  1994cited by this paper
• Intracellular turnover of cystic fibrosis transmembrane conductance regulator. Inefficient processing and rapid degradation of wild-type and mutant proteins.

  1994influential reference
• A protein translocation defect linked to ubiquitin conjugation at the endoplasmic reticulum

  1993cited by this paper
• The common variant of cystic fibrosis transmembrane conductance regulator is recognized by hsp70 and degraded in a pre-Golgi nonlysosomal compartment.

  1993cited by this paper
• The endoplasmic reticulum as a site of protein degradation.

  1993cited by this paper
• Translocation of TCR alpha chains into the lumen of the endoplasmic reticulum and their degradation.

  1993cited by this paper
• Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis.

  1993cited by this paper
• The Endoplasmic Reticulum as a Site of Protein Degradation

  1993cited by this paper
• The spectrum of cystic fibrosis mutations.

  1992cited by this paper
• Mislocalization of ΔF508 CFTR in cystic fibrosis sweat gland

  1992cited by this paper
• Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive

  1992cited by this paper
• Proteolysis, proteasomes and antigen presentation

  1992cited by this paper
• Mislocalization of delta F508 CFTR in cystic fibrosis sweat gland.

  1992cited by this paper
• Altered chloride ion channel kinetics associated with the ΔF508 cystic fibrosis mutation

  1991cited by this paper
• Functional differences among nonerythroid anion exchangers expressed in a transfected human cell line.

  1991cited by this paper
• Chloride conductance expressed by delta F508 and other mutant CFTRs in Xenopus oocytes.

  1991cited by this paper
• Structure of lactacystin, a new microbial metabolite which induces differentiation of neuroblastoma cells.

  1991cited by this paper
• Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation.

  1991cited by this paper
• A general method for rapid site-directed mutagenesis using the polymerase chain reaction.

  1990cited by this paper
• Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis.

  1990influential reference
• Protein degradation in the endoplasmic reticulum.

  1990cited by this paper
• Identification of mutations in regions corresponding to the two putative nucleotide (ATP)-binding folds of the cystic fibrosis gene.

  1990cited by this paper
• The "megaprimer" method of site-directed mutagenesis.

  1990cited by this paper
• A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein.

  1989influential reference
• Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

  1989cited by this paper
• Regulation of protein degradation rates in eukaryotes.

  1989cited by this paper
• A Chinese hamster cell cycle mutant arrested at G2 phase has a temperature-sensitive ubiquitin-activating enzyme, E1.

  1988cited by this paper

• Functional integrity of the SEL1L–HRD1 complex is critical for endoplasmic reticulum–associated degradation and organismal viability

  2026cites this paper
• RFFL-mediated protein quality control limits functional rescue of TRID-CFTR modulator combination therapy for cystic fibrosis nonsense mutations

  2026cites this paper
• Structural basis and pathological implications of the dimeric OS9-SEL1L-HRD1 ERAD Core Complex

  2026cites this paper
• The role of ER-associated degradation and ER-phagy in health and disease

  2026cites this paper
• Target Identification with Live-Cell Photoaffinity Labeling and Mechanism of Action Elucidation of ARN23765, a Highly Potent CFTR Corrector.

  2025cites this paper
• Pathogenic germline variants in Chinese pancreatic adenocarcinoma patients

  2025cites this paper
• Barriers to the Pharmacologic Rescue of W1282X CFTR

  2025cites this paper
• Structural basis and pathological implications of the dimeric OS9-SEL1L-HRD1 ERAD Core Complex

  2025cites this paper
• Reconstitution of CFTR ubiquitination identifies lysine-420 as a regulator of cell surface residence and current

  2025cites this paper
• CFTR corrector C17 rescues defective SERCA1 in bovine pseudomyotonia: a potential therapy for Brody myopathy

  2025cites this paper
• Functional integrity of the SEL1L-HRD1 complex is critical for ERAD and organismal viability

  2025cites this paper
• Functional rescue of a fatal ERAD mutation via alternative splicing

  2025cites this paper
• Integrative Omics reveals changes in the cellular landscape of peroxisome-deficient pex3 yeast cells.

  2025cites this paper
• Deubiquitinase-Targeting Chimeras (DUBTACs) as a Potential Paradigm-Shifting Drug Discovery Approach.

  2025cites this paper
• Functional rescue of F508del-CFTR through revertant mutations introduced by CRISPR base editing.

  2025cites this paper
• Antisense oligonucleotide targeting the E3 ligase RFFL potentiates CFTR modulator efficacy in CF primary bronchial epithelial cells

  2025cites this paper
• SEL1L–HRD1-mediated ERAD in mammals

  2025cites this paper
• Inhibitors of the ubiquitin-proteasome system rescue cellular levels and ion transport function of pathogenic pendrin (SLC26A4) protein variants

  2025cites this paper
• Evolutionary conserved regulation of TFEB stability by the E3 ubiquitin ligase WWP2 modulates response to stress in vivo

  2025cites this paper
• Synergistic Control of Mitochondrial Dynamics and Function by ERAD and Autophagy in Brown Adipocytes

  2025cites this paper
• Tubular ER structures shaped by ER-phagy receptors engage in stress-induced Golgi bypass.

  2025cites this paper
• Mechanisms of transmembrane domain recognition during endoplasmic reticulum quality control.

  2025cites this paper
• Oligosaccharyltransferase Is Involved in Targeting to ER-Associated Degradation

  2025cites this paper
• Targeted recruitment of USP15 enhances CTLA4 surface levels and restricts its degradation

  2025cites this paper
• Programmable protein stabilization with language model-derived peptide guides

  2025cites this paper
• Ivacaftor-tezacaftor-elexacaftor, tezacaftor-ivacaftor and lumacaftor-ivacaftor for treating cystic fibrosis: a systematic review and economic evaluation.

  2025cites this paper
• The co-chaperone DNAJA2 buffers proteasomal degradation of cytosolic proteins with missense mutations

  2024cites this paper
• Applications of protein ubiquitylation and deubiquitylation in drug discovery

  2024cites this paper
• Cystic Fibrosis Modulator Therapies: Bridging Insights from CF to other Membrane Protein Misfolding Diseases

  2024cites this paper
• The expression system influences stability, maturation efficiency, and oligomeric properties of the potassium-chloride co-transporter KCC2.

  2024cites this paper
• Integrative Omics reveals changes in the cellular landscape of yeast without peroxisomes

  2024cites this paper
• HERC3 facilitates ERAD of select membrane proteins by recognizing membrane-spanning domains

  2024cites this paper
• Functional rescue of F508del-CFTR through revertant mutations introduced by CRISPR base editing

  2024cites this paper
• CFTR complex alleles and phenotypic variability in cystic fibrosis disease.

  2024cites this paper
• Targeting ERCC2 with siRNA Self-Assembled Nanoparticles to Enhance the Cisplatin Response in Bladder Cancer

  2024cites this paper
• Characterization of hyperactive mutations in the renal potassium channel ROMK uncovers unique effects on channel biogenesis and ion conductance

  2024cites this paper
• Valproate Mediated Proteasome Dysfunctions Induce Apoptosis

  2024cites this paper
• SUMOylation Inhibition Enhances Protein Transcription under CMV Promoter: A Lesson from a Study with the F508del-CFTR Mutant

  2024cites this paper
• Inhibition of the ubiquitin-proteasome system reduces the abundance of pyruvate dehydrogenase kinase 1 in cultured myotubes

  2024cites this paper
• Targeting ubiquitination machinery in cystic fibrosis: Where do we stand?

  2024influential citation
• Programmable Protein Stabilization with Language Model-Derived Peptide Guides

  2024cites this paper
• The folding pathway of ABC transporter CFTR: effective and robust.

  2024cites this paper
• Evidence for intracellular Pseudomonas aeruginosa

  2024cites this paper
• Ligand-based virtual-screening identified a novel CFTR ligand which improves the defective cell surface expression of misfolded ABC transporters

  2024cites this paper
• Mechanisms of substrate processing during ER-associated protein degradation

  2023cites this paper
• Exploitation of Proximity-Mediated Effects in Drug Discovery: An Update of Recent Research Highlights in Perturbing Pathogenic Proteins and Correlated Issues.

  2023cites this paper
• Unraveling the roles of endoplasmic reticulum-associated degradation in metabolic disorders

  2023cites this paper
• Small-molecule correctors divert CFTR-F508del from ERAD by stabilizing sequential folding states

  2023cites this paper
• Engineered tRNAs suppress nonsense mutations in cells and in vivo

  2023cites this paper
• ER-associated degradation in cystinosis pathogenesis and the prospects of precision medicine

  2023cites this paper
• UBE3C Facilitates the ER-Associated and Peripheral Degradation of Misfolded CFTR

  2023cites this paper
• Copper homeostasis and the ubiquitin proteasome system

  2023cites this paper
• Respiratory Infection and Inflammation in Cystic Fibrosis: A Dynamic Interplay among the Host, Microbes, and Environment for the Ages

  2023cites this paper
• Cav1.4 congenital stationary night blindness is associated with an increased rate of proteasomal degradation

  2023cites this paper
• Genome mining yields new disease-associated ROMK variants with distinct defects

  2023cites this paper
• The generation of detergent-insoluble clipped fragments from an ERAD substrate in mammalian cells

  2023cites this paper
• Genome mining yields putative disease-associated ROMK variants with distinct defects

  2023cites this paper
• Global analysis of suppressor mutations that rescue human genetic defects

  2023cites this paper
• Elexacaftor/VX-445–mediated CFTR interactome remodeling reveals differential correction driven by mutation-specific translational dynamics

  2023cites this paper
• Small molecule correctors divert CFTR-F508del from ERAD by stabilizing sequential folding states

  2023cites this paper
• Future therapies for cystic fibrosis

  2023cites this paper
• A Proteomic Survey of the Cystic Fibrosis Transmembrane Conductance Regulator Surfaceome

  2023cites this paper
• SUMO-3 promotes the ubiquitin-dependent turnover of TRIM55.

  2023cites this paper
• Elexacaftor Mediates the Rescue of F508del CFTR Functional Expression Interacting with MSD2

  2023cites this paper
• Transmembrane Helices 7 and 8 Confer Aggregation Sensitivity to the Cystic Fibrosis Transmembrane Conductance Regulator

  2023cites this paper
• Mutation profiling of the c.1521_1523delCTT (p.Phe508del, F508del) cystic fibrosis transmembrane conductance regulator allele using haplotype‐resolved long‐read next generation sequencing

  2022cites this paper
• Order through destruction: how ER‐associated protein degradation contributes to organelle homeostasis

  2022cites this paper
• Differential Analysis of Gly211Val and Gly286Val Mutations Affecting Sarco(endo)plasmic Reticulum Ca2+-ATPase (SERCA1) in Congenital Pseudomyotonia Romagnola Cattle

  2022cites this paper
• Pharmacological chaperone-rescued cystic fibrosis CFTR-F508del mutant overcomes PRAF2-gated access to endoplasmic reticulum exit sites

  2022cites this paper
• KDM2A and KDM3B as Potential Targets for the Rescue of F508del-CFTR

  2022cites this paper
• Opposite regulation of F508del-CFTR biogenesis by four poly-lysine ubiquitin chains In vitro.

  2022cites this paper
• A small-molecule inhibitor and degrader of the RNF5 ubiquitin ligase

  2022cites this paper
• End of the road: from the ER to the proteasome

  2022cites this paper
• TMED3 Complex Mediates ER Stress‐Associated Secretion of CFTR, Pendrin, and SARS‐CoV‐2 Spike

  2022cites this paper
• DUB to the rescue.

  2022cites this paper
• HRD1 in human malignant neoplasms: Molecular mechanisms and novel therapeutic strategy for cancer.

  2022cites this paper
• Forskolin Stimulates Estrogen Receptor (ER) α Transcriptional Activity and Protects ER from Degradation by Distinct Mechanisms

  2022cites this paper
• Endoplasmic Reticulum-Associated Protein Degradation.

  2022cites this paper
• The NSAID glafenine rescues class 2 CFTR mutants via cyclooxygenase 2 inhibition of the arachidonic acid pathway

  2022cites this paper
• Targeting trafficking as a therapeutic avenue for misfolded GPCRs leading to endocrine diseases

  2022cites this paper
• ER-phagy: mechanisms, regulation, and diseases connected to the lysosomal clearance of the endoplasmic reticulum

  2022cites this paper
• Targeting the E1 ubiquitin-activating enzyme (UBA1) improves elexacaftor/tezacaftor/ivacaftor efficacy towards F508del and rare misfolded CFTR mutants

  2022cites this paper
• Deubiquitinase-targeting chimeras for targeted protein stabilization

  2022cites this paper
• L1 Syndrome Prenatal Diagnosis Supplemented by Functional Analysis of One L1CAM Gene Missense Variant

  2021cites this paper
• Golgi Alpha1,2-Mannosidase IA Promotes Efficient Endoplasmic Reticulum-Associated Degradation of NKCC2

  2021cites this paper
• Tracheal Stenosis : One Region Experience

  2021cites this paper
• Revisiting CFTR Interactions: Old Partners and New Players

  2021cites this paper
• SLC26A9 is selected for endoplasmic reticulum associated degradation (ERAD) via Hsp70-dependent targeting of the soluble STAS domain.

  2021cites this paper
• Nonspecific binding of common anti-CFTR antibodies in ciliated cells of human airway epithelium

  2021cites this paper
• Small-molecule drugs for cystic fibrosis: Where are we now?

  2021cites this paper
• S-nitrosothiols signaling in cystic fibrosis airways

  2021cites this paper
• Loss of Function of Mutant IDS Due to Endoplasmic Reticulum-Associated Degradation: New Therapeutic Opportunities for Mucopolysaccharidosis Type II

  2021cites this paper
• Suppression of Pyruvate Dehydrogenase Kinase by Dichloroacetate in Cancer and Skeletal Muscle Cells Is Isoform Specific and Partially Independent of HIF-1α

  2021influential citation
• The Targeting of Native Proteins to the Endoplasmic Reticulum-Associated Degradation (ERAD) Pathway: An Expanding Repertoire of Regulated Substrates

  2021cites this paper
• Can two wrongs make a right? F508del-CFTR ion channel rescue by second-site mutations in its transmembrane domains

  2021cites this paper
• NBD2 Is Required for the Rescue of Mutant F508del CFTR by a Thiazole-Based Molecule: A Class II Corrector for the Multi-Drug Therapy of Cystic Fibrosis

  2021cites this paper
• SARS-CoV-2 and Cystic Fibrosis: Expectations Versus Reality, a Literature Review

  2021cites this paper
• Identification of Nephrogenic Therapeutic Biomarkers of Wilms Tumor Using Machine Learning

  2021cites this paper
• Maintenance of organellar protein homeostasis by ER-associated degradation and related mechanisms.

  2021cites this paper
• Deubiquitinase-Targeting Chimeras for Targeted Protein Stabilization

  2021cites this paper